{"entity":{"type":"insider","cik":"0001546216","url":"/insider/0001546216","json_url":"/insider/0001546216.json","name":"Goff Brian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":15,"first":"2018-02-08","last":"2026-04-06","span_basis":"filed_date"},"name_variants":[{"name":"Goff Brian","source":"filing","n_filings":15,"first_seen":"2018-02-08","last_seen":"2026-04-06"}],"transactions":[{"id":5834096,"accession":"0001439222-26-000057","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-26-000057","line_url":"/filing/0001439222-26-000057","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19068.0,"shares_display":"19,068","price_per_share":34.71,"price_display":"34.71","price_state":"stated","total_value":661850.28,"total_display":"661,850.28","total_whole":"661,850","shares_owned_after":177604.0,"shares_owned_after_display":"177,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-06","scope":"insider","n_lines":2},{"id":6211332,"accession":"0001439222-26-000044","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001439222-26-000044","line_url":"/filing/0001439222-26-000044","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18055.0,"shares_display":"18,055","price_per_share":28.96,"price_display":"28.96","price_state":"stated","total_value":522872.8,"total_display":"522,872.80","total_whole":"522,873","shares_owned_after":157466.0,"shares_owned_after_display":"157,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider","n_lines":3},{"id":6038098,"accession":"0001439222-26-000008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-26-000008","line_url":"/filing/0001439222-26-000008","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18703.0,"shares_display":"18,703","price_per_share":27.09,"price_display":"27.09","price_state":"stated","total_value":506664.27,"total_display":"506,664.27","total_whole":"506,664","shares_owned_after":136583.0,"shares_owned_after_display":"136,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-30","filed_date":"2026-01-02","scope":"insider","n_lines":2},{"id":4647958,"accession":"0001439222-25-000093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000093","line_url":"/filing/0001439222-25-000093#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11085.0,"shares_display":"11,085","price_per_share":36.67,"price_display":"36.67","price_state":"stated","total_value":406486.95,"total_display":"406,486.95","total_whole":"406,487","shares_owned_after":123528.0,"shares_owned_after_display":"123,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-08","filed_date":"2025-08-12","scope":"insider"},{"id":4287064,"accession":"0001439222-25-000063","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-25-000063","line_url":"/filing/0001439222-25-000063","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18700.0,"shares_display":"18,700","price_per_share":33.54,"price_display":"33.54","price_state":"stated","total_value":627198.0,"total_display":"627,198.00","total_whole":"627,198","shares_owned_after":105401.0,"shares_owned_after_display":"105,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-26","scope":"insider","n_lines":2},{"id":5089697,"accession":"0001439222-25-000015","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-25-000015","line_url":"/filing/0001439222-25-000015","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12947.0,"shares_display":"12,947","price_per_share":35.54,"price_display":"35.54","price_state":"stated","total_value":460136.38,"total_display":"460,136.38","total_whole":"460,136","shares_owned_after":92345.0,"shares_owned_after_display":"92,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider","n_lines":2},{"id":2251321,"accession":"0001439222-24-000123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000123","line_url":"/filing/0001439222-24-000123#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11091.0,"shares_display":"11,091","price_per_share":42.75,"price_display":"42.75","price_state":"stated","total_value":474140.25,"total_display":"474,140.25","total_whole":"474,140","shares_owned_after":78792.0,"shares_owned_after_display":"78,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-08","filed_date":"2024-08-12","scope":"insider"},{"id":2786538,"accession":"0001439222-24-000073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000073","line_url":"/filing/0001439222-24-000073#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12115.0,"shares_display":"12,115","price_per_share":48.84,"price_display":"48.84","price_state":"stated","total_value":591696.6,"total_display":"591,696.60","total_whole":"591,697","shares_owned_after":67192.0,"shares_owned_after_display":"67,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-07","scope":"insider"},{"id":2315366,"accession":"0001439222-24-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000048","line_url":"/filing/0001439222-24-000048#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4156.0,"shares_display":"4,156","price_per_share":32.57,"price_display":"32.57","price_state":"stated","total_value":135360.92,"total_display":"135,360.92","total_whole":"135,361","shares_owned_after":53780.0,"shares_owned_after_display":"53,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-05","scope":"insider"},{"id":2104211,"accession":"0001439222-24-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000014","line_url":"/filing/0001439222-24-000014#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7635.0,"shares_display":"7,635","price_per_share":21.64,"price_display":"21.64","price_state":"stated","total_value":165221.4,"total_display":"165,221.40","total_whole":"165,221","shares_owned_after":49436.0,"shares_owned_after_display":"49,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-24","scope":"insider"},{"id":3080456,"accession":"0001439222-24-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000010","line_url":"/filing/0001439222-24-000010#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12066.0,"shares_display":"12,066","price_per_share":22.99,"price_display":"22.99","price_state":"stated","total_value":277397.34,"total_display":"277,397.34","total_whole":"277,397","shares_owned_after":40053.0,"shares_owned_after_display":"40,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-09","scope":"insider"},{"id":8686334,"accession":"0001439222-23-000123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000123","line_url":"/filing/0001439222-23-000123#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10178.0,"shares_display":"10,178","price_per_share":25.48,"price_display":"25.48","price_state":"stated","total_value":259335.44,"total_display":"259,335.44","total_whole":"259,335","shares_owned_after":26592.0,"shares_owned_after_display":"26,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-10","scope":"insider"},{"id":8366505,"accession":"0001439222-23-000103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000103","line_url":"/filing/0001439222-23-000103#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11449.0,"shares_display":"11,449","price_per_share":28.36,"price_display":"28.36","price_state":"stated","total_value":324693.64,"total_display":"324,693.64","total_whole":"324,694","shares_owned_after":14079.0,"shares_owned_after_display":"14,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-06-30","scope":"insider"},{"id":6090487,"accession":"0000899866-18-000102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-18-000102","line_url":"/filing/0000899866-18-000102#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1645.0,"shares_display":"1,645","price_per_share":118.53,"price_display":"118.53","price_state":"stated","total_value":194981.85,"total_display":"194,981.85","total_whole":"194,982","shares_owned_after":36257.0,"shares_owned_after_display":"36,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-12","scope":"insider"},{"id":6179144,"accession":"0000899866-18-000042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-18-000042","line_url":"/filing/0000899866-18-000042#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001546216","owner_name":"Goff Brian","owner_display_name":"Goff Brian","owner_url":"/insider/0001546216","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1651.0,"shares_display":"1,651","price_per_share":116.31,"price_display":"116.31","price_state":"stated","total_value":192027.81,"total_display":"192,027.81","total_whole":"192,028","shares_owned_after":28962.0,"shares_owned_after_display":"28,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Director, Officer (Chief Executive Officer)","n_filings":13,"first_seen":"2023-06-30","last_seen":"2026-04-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Officer (EVP & Chief Commercial Officer)","n_filings":2,"first_seen":"2018-02-08","last_seen":"2018-06-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001546216","retrieved_at":"2026-08-26T09:31:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}